XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Mar. 31, 2023
Revenue:      
Total net revenues $ 68,522 $ 59,333  
Cost of goods sold $ 21,867 $ 18,830  
Cost, Product and Service [Extensible Enumeration] Product revenue, net Product revenue, net Product revenue, net
Gross profit $ 46,655 $ 40,503  
Operating expenses:      
Selling, general and administrative 56,640 45,123  
Research and development 2,212 2,078  
Revaluation of contingent royalty obligation payable to Evolus Founders 2,151 1,578  
Depreciation and amortization 824 646  
Total operating expenses 61,827 49,425  
Loss from operations (15,172) (8,922)  
Other income (expense):      
Interest income 710 517  
Interest expense (4,415) (4,702)  
Other income, net 57 45  
Loss before income taxes: (18,820) (13,062)  
Income tax expense 72 47  
Net loss (18,892) (13,109)  
Other comprehensive loss:      
Unrealized income (loss), net of tax 66 (130)  
Comprehensive loss $ (18,826) $ (13,239)  
Net loss per share, basic (in dollars per share) $ (0.30) $ (0.22)  
Net loss per share, diluted (in dollars per share) $ (0.30) $ (0.22)  
Weighted-average shares outstanding used to compute basic net loss per share (in shares) 63,696,627 58,797,311  
Weighted-average shares outstanding used to compute diluted net loss per share (in shares) 63,696,627 58,797,311  
Product revenue, net      
Revenue:      
Total net revenues $ 68,074 $ 58,964  
Service revenue      
Revenue:      
Total net revenues $ 448 $ 369